<?xml version="1.0" encoding="UTF-8"?>
<p>The antigenicity of selected A(H1N1)pdm09 isolates was characterized by hemagglutination inhibition (HI) assay following the WHO manual using guinea pig red blood cells and commercially available vaccine strain antisera for 2017â€“2018 seasons in Japan (A/Singapore/GP1908/2015, A/Michigan/45/2015-like strain) at the Department of Virology, Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata, Japan [
 <xref rid="pone.0229601.ref011" ref-type="bibr">11</xref>].
</p>
